{"id":5503,"date":"2022-07-21T05:08:10","date_gmt":"2022-07-21T05:08:10","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=5503"},"modified":"2023-08-29T17:54:54","modified_gmt":"2023-08-29T17:54:54","slug":"incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=5503","title":{"rendered":"Incannex Healthcare \u5c06\u5728\u4f26\u7406\u6279\u51c6\u540e\u5f00\u59cb IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c"},"content":{"rendered":"

Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u8fd9\u662f\u5f00\u59cb\u5176\u591a\u7528\u9014\u6297\u708e\u836f IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u524d\u7684\u6700\u540e\u4e00\u4e2a\u76d1\u7ba1\u969c\u788d\u3002<\/p>\n

IHL-675A \u5305\u542b\u5927\u9ebb\u4e8c\u915a (CBD) \u548c\u7f9f\u6c2f\u55b9 (HCQ) \u7684\u56fa\u5b9a\u5242\u91cf\u7ec4\u5408\u3002<\/p>\n

\u5728\u4e4b\u524d\u7684\u4f53\u5916\u548c\u4f53\u5185\u7814\u7a76\u4e2d\uff0cIncannex \u5df2\u7ecf\u8bc1\u660e CBD \u548c HCQ \u534f\u540c\u4f5c\u7528\u4ee5\u6291\u5236\u5173\u952e\u708e\u75c7\u7ec6\u80de\u56e0\u5b50\u7684\u4ea7\u751f\u3002\u4e34\u5e8a\u524d\u7814\u7a76\u8868\u660e\uff0cIHL-675A \u6bd4\u5355\u72ec\u7684 CBD \u5177\u6709\u66f4\u5f3a\u7684\u6297\u708e\u7279\u6027\u3002<\/p>\n

\u5728\u8bc4\u4f30\u5176\u4e34\u5e8a\u524d\u7814\u7a76\u6570\u636e\u540e\uff0cIncannex \u8868\u793a IHL-675A \u662f\u4e00\u79cd\u591a\u7528\u9014\u836f\u7269\uff0c\u9002\u7528\u4e8e\u6cbb\u7597\u708e\u75c7\u6027\u80ba\u90e8\u75be\u75c5\uff08\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u3001COPD\u3001\u54ee\u5598\u548c\u652f\u6c14\u7ba1\u708e\uff09\u3001\u708e\u75c7\u6027\u80a0\u75c5\u548c\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u3002<\/p>\n

IHL-675A \u7684\u53e6\u4e00\u4e2a\u4e3b\u8981\u6210\u5206\u662f HCQ\uff0c\u5b83\u662f\u4e00\u79cd\u8c03\u8282\u514d\u75ab\u7cfb\u7edf\u6d3b\u6027\u7684\u201c\u7f13\u89e3\u75be\u75c5\u7684\u6297\u98ce\u6e7f\u836f\u7269\u201d\u3002<\/p>\n

\u5b83\u53ef\u4ee5\u6539\u53d8\u6f5c\u5728\u7684\u75be\u75c5\u8fc7\u7a0b\uff0c\u5305\u62ec\u8fc7\u5ea6\u6d3b\u8dc3\u7684\u514d\u75ab\u7cfb\u7edf\uff0c\u800c\u4e0d\u4ec5\u4ec5\u662f\u6cbb\u7597\u75c7\u72b6\u3002<\/p>\n

\u7c7b\u98ce\u6e7f\u5173\u8282\u708e<\/h2>\n

HCQ \u4ee5 Plaquenil \u7684\u5f62\u5f0f\u4e0a\u5e02\u9500\u552e\uff0c\u5e76\u4e14\u5df2\u7ecf\u88ab\u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u3002\u5355\u72ec\u4f7f\u7528 HCQ \u53ef\u4ee5\u51cf\u8f7b\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684\u75bc\u75db\u548c\u80bf\u80c0\uff0c\u540c\u65f6\u53ef\u80fd\u9884\u9632\u5173\u8282\u635f\u4f24\u5e76\u964d\u4f4e\u957f\u671f\u6b8b\u75be\u7684\u98ce\u9669\u3002<\/p>\n

\u4e34\u5e8a\u524d\u7814\u7a76\u8868\u660e\uff0cIHL-675A \u53ef\u5c06 HCQ \u5242\u91cf\u51cf\u5c11\u591a\u8fbe 10 \u500d\uff0c\u800c\u4e0d\u4f1a\u727a\u7272\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u52a8\u7269\u6a21\u578b\u7684\u6cbb\u7597\u6548\u679c\u3002<\/p>\n

Incannex \u6307\u51fa\uff0c\u51cf\u5c11\u5173\u8282\u708e\u60a3\u8005\u7684 HCQ \u5242\u91cf\u5177\u6709\u91cd\u8981\u4ef7\u503c\uff0c\u56e0\u4e3a\u957f\u671f\u4f7f\u7528\u4e0e\u5fc3\u8840\u7ba1\u548c\u773c\u90e8\u526f\u4f5c\u7528\u6709\u5173\u3002<\/p>\n

CMAX \u4e34\u5e8a\u7814\u7a76\u7684 1 \u671f\u4e34\u5e8a\u7814\u7a76<\/h2>\n

\u7ecf\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a\u6279\u51c6\uff0cIncannex \u5c06\u5728\u5357\u6fb3\u5927\u5229\u4e9a\u7684 CMAX Clinical Research\u5f00\u59cb 1 \u671f\u8bd5\u9a8c\u3002<\/p>\n

Avance Clinical \u6b63\u5728\u7ba1\u7406\u8fd9\u9879\u7814\u7a76\uff0c\u8be5\u7814\u7a76\u5c06\u8bc4\u4f30 IHL-675A \u7684\u836f\u4ee3\u52a8\u529b\u5b66\u3001\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u3002<\/p>\n

\u5728\u4e3a\u8bd5\u9a8c\u505a\u597d\u51c6\u5907\u65f6\uff0cIncannex \u5df2\u7ecf\u5b8c\u6210\u4e86 IHL-675A \u8f6f\u80f6\u56ca\u7684\u5236\u9020\uff0c\u5e76\u8fdb\u884c\u4e86\u957f\u671f\u7a33\u5b9a\u6027\u7814\u7a76\uff0c\u4ee5\u786e\u5b9a\u4ea7\u54c1\u7684\u201c\u4fdd\u8d28\u671f\u201d\u3002<\/p>\n

Incannex \u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u603b\u7ecf\u7406 Joel Latham \u8868\u793a\uff0c\u83b7\u5f97\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6\u662f\u63a8\u8fdb IHL-675A \u6cbb\u7597\u708e\u75c7\u6027\u75be\u75c5\u60a3\u8005\u7684\u201c\u91cd\u8981\u91cc\u7a0b\u7891\u201d\u3002<\/p>\n

\u201c\u8d8a\u6765\u8d8a\u591a\u7684\u8d8b\u52bf\u662f\u60a3\u8005\u4f7f\u7528 CBD \u6765\u6cbb\u7597\u6216\u8865\u5145\u4ed6\u4eec\u73b0\u6709\u7684\u708e\u75c7\u6027\u75be\u75c5\u6cbb\u7597\u65b9\u6cd5\u3002\u201d<\/p>\n

\u201c\u6211\u4eec\u5728\u5df2\u5efa\u7acb\u7684\u708e\u75c7\u6a21\u578b\u4e2d\u89c2\u5bdf\u5230\uff0cIHL-675A \u662f\u4e00\u79cd\u6bd4\u5355\u72ec\u4f7f\u7528 CBD \u66f4\u5f3a\u7684\u6297\u708e\u5927\u9ebb\u7d20\u836f\u7269\u2014\u2014\u56e0\u6b64\u6211\u4eec\u5f88\u9ad8\u5174\u4e5f\u5f88\u9ad8\u5174\u9996\u6b21\u5c06 IHL-675A \u5e26\u5230\u4e34\u5e8a\u3002\u201d<\/p>\n

\u8be5\u8bd5\u9a8c\u7684\u60a3\u8005\u62db\u52df\u8ba1\u5212\u4e8e\u4e0b\u4e2a\u6708\u5f00\u59cb\uff0c\u4e09\u7ec4 12 \u540d\u53c2\u4e0e\u8005\u63a5\u53d7 IHL-675A\u3001CBD \u6216 HCQ\u3002<\/p>\n

\u8bd5\u9a8c\u76ee\u6807<\/h2>\n

Incannex \u9996\u5e2d\u79d1\u5b66\u5b98 Mark Bleackley \u535a\u58eb\u8bf4\uff0c\u8be5\u8bd5\u9a8c\u7684\u76ee\u7684\u662f\u8bc1\u660e IHL-675A \u4e0e\u5355\u72ec\u4f7f\u7528 CBD \u6216 HCQ \u76f8\u6bd4\u6ca1\u6709\u526f\u4f5c\u7528\u6216\u526f\u4f5c\u7528\u6700\u5c0f\u3002<\/p>\n

\u8be5\u7814\u7a76\u7ed3\u679c\u5c06\u6210\u4e3a\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40 IHL-675A \u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u3001\u708e\u75c7\u6027\u80a0\u75c5\u548c\u80ba\u90e8\u708e\u75c7\u7684\u4e09\u9879\u7814\u7a76\u6027\u65b0\u836f (IND) \u7533\u8bf7\u7684\u4e00\u90e8\u5206\u3002<\/p>\n

\u8fd9\u4e09\u4e2a\u6307\u6807\u4ee3\u8868\u4e86\u5168\u7403\u5e74\u5ea6\u5e02\u573a\u89c4\u6a21\u8d85\u8fc7 1250 \u4ebf\u7f8e\u5143\u3002<\/p>\n

Incannex \u5df2\u7ecf\u5b8c\u6210\u4e86\u4e0e FDA \u7684 IND \u524d\u4f1a\u8bae\uff0c\u8ba8\u8bba\u5728\u7f8e\u56fd\u5f00\u53d1 IHL-675A \u7684\u76d1\u7ba1\u9014\u5f84\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u8fd9\u662f\u5f00\u59cb\u5176\u591a\u7528\u9014\u6297\u708e\u836f IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u524d\u7684\u6700\u540e\u4e00\u4e2a\u76d1\u7ba1\u969c\u788d\u3002 IHL-675A \u5305\u542b\u5927\u9ebb\u4e8c\u915a (CBD) \u548c\u7f9f\u6c2f\u55b9 (HCQ) \u7684\u56fa\u5b9a\u5242\u91cf\u7ec4\u5408\u3002 \u5728\u4e4b\u524d\u7684\u4f53\u5916\u548c\u4f53\u5185\u7814\u7a76\u4e2d\uff0cIncannex \u5df2\u7ecf\u8bc1\u660e CBD \u548c HCQ \u534f\u540c\u4f5c\u7528\u4ee5\u6291\u5236\u5173\u952e\u708e\u75c7\u7ec6\u80de\u56e0\u5b50\u7684\u4ea7\u751f\u3002\u4e34\u5e8a\u524d\u7814\u7a76\u8868\u660e\uff0cIHL-675A \u6bd4\u5355\u72ec\u7684 CBD \u5177\u6709\u66f4\u5f3a\u7684\u6297\u708e\u7279\u6027\u3002 \u5728\u8bc4\u4f30\u5176\u4e34\u5e8a\u524d\u7814\u7a76\u6570\u636e\u540e\uff0cIncannex \u8868\u793a IHL-675A \u662f\u4e00\u79cd\u591a\u7528\u9014\u836f\u7269\uff0c\u9002\u7528\u4e8e\u6cbb\u7597\u708e\u75c7\u6027\u80ba\u90e8\u75be\u75c5\uff08\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u3001COPD\u3001\u54ee\u5598\u548c\u652f\u6c14\u7ba1\u708e\uff09\u3001\u708e\u75c7\u6027\u80a0\u75c5\u548c\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u3002 IHL-675A \u7684\u53e6\u4e00\u4e2a\u4e3b\u8981\u6210\u5206\u662f HCQ\uff0c\u5b83\u662f\u4e00\u79cd\u8c03\u8282\u514d\u75ab\u7cfb\u7edf\u6d3b\u6027\u7684\u201c\u7f13\u89e3\u75be\u75c5\u7684\u6297\u98ce\u6e7f\u836f\u7269\u201d\u3002 \u5b83\u53ef\u4ee5\u6539\u53d8\u6f5c\u5728\u7684\u75be\u75c5\u8fc7\u7a0b\uff0c\u5305\u62ec\u8fc7\u5ea6\u6d3b\u8dc3\u7684\u514d\u75ab\u7cfb\u7edf\uff0c\u800c\u4e0d\u4ec5\u4ec5\u662f\u6cbb\u7597\u75c7\u72b6\u3002 \u7c7b\u98ce\u6e7f\u5173\u8282\u708e HCQ \u4ee5 Plaquenil \u7684\u5f62\u5f0f\u4e0a\u5e02\u9500\u552e\uff0c\u5e76\u4e14\u5df2\u7ecf\u88ab\u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u3002\u5355\u72ec\u4f7f\u7528 HCQ \u53ef\u4ee5\u51cf\u8f7b\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684\u75bc\u75db\u548c\u80bf\u80c0\uff0c\u540c\u65f6\u53ef\u80fd\u9884\u9632\u5173\u8282\u635f\u4f24\u5e76\u964d\u4f4e\u957f\u671f\u6b8b\u75be\u7684\u98ce\u9669\u3002 \u4e34\u5e8a\u524d\u7814\u7a76\u8868\u660e\uff0cIHL-675A \u53ef\u5c06 HCQ \u5242\u91cf\u51cf\u5c11\u591a\u8fbe 10 \u500d\uff0c\u800c\u4e0d\u4f1a\u727a\u7272\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u52a8\u7269\u6a21\u578b\u7684\u6cbb\u7597\u6548\u679c\u3002 Incannex \u6307\u51fa\uff0c\u51cf\u5c11\u5173\u8282\u708e\u60a3\u8005\u7684 HCQ \u5242\u91cf\u5177\u6709\u91cd\u8981\u4ef7\u503c\uff0c\u56e0\u4e3a\u957f\u671f\u4f7f\u7528\u4e0e\u5fc3\u8840\u7ba1\u548c\u773c\u90e8\u526f\u4f5c\u7528\u6709\u5173\u3002 CMAX \u4e34\u5e8a\u7814\u7a76\u7684 1 \u671f\u4e34\u5e8a\u7814\u7a76 \u7ecf\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a\u6279\u51c6\uff0cIncannex \u5c06\u5728\u5357\u6fb3\u5927\u5229\u4e9a\u7684… Continue reading Incannex Healthcare \u5c06\u5728\u4f26\u7406\u6279\u51c6\u540e\u5f00\u59cb IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":18751,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[33],"yoast_head":"\nIncannex Healthcare \u5c06\u5728\u4f26\u7406\u6279\u51c6\u540e\u5f00\u59cb IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c<\/title>\n<meta name=\"description\" content=\"Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u8fd9\u662f\u5f00\u59cb\u5176\u591a\u7528\u9014\u6297\u708e\u836f IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u524d\u7684\u6700\u540e\u4e00\u4e2a\u76d1\u7ba1\u969c\u788d\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Incannex Healthcare \u5c06\u5728\u4f26\u7406\u6279\u51c6\u540e\u5f00\u59cb IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\" \/>\n<meta property=\"og:description\" content=\"Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u8fd9\u662f\u5f00\u59cb\u5176\u591a\u7528\u9014\u6297\u708e\u836f IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u524d\u7684\u6700\u540e\u4e00\u4e2a\u76d1\u7ba1\u969c\u788d\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-21T05:08:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:54:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Incannex-Healthcare-ASX-IHL-phase-1-clinical-trial-IHL-675A-inflammatory-lung-conditions-bowel-disease-rheumatoid-arthritis.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval\/\",\"name\":\"Incannex Healthcare \u5c06\u5728\u4f26\u7406\u6279\u51c6\u540e\u5f00\u59cb IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2022-07-21T05:08:10+00:00\",\"dateModified\":\"2023-08-29T17:54:54+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u8fd9\u662f\u5f00\u59cb\u5176\u591a\u7528\u9014\u6297\u708e\u836f IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u524d\u7684\u6700\u540e\u4e00\u4e2a\u76d1\u7ba1\u969c\u788d\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Incannex Healthcare \u5c06\u5728\u4f26\u7406\u6279\u51c6\u540e\u5f00\u59cb IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Incannex Healthcare \u5c06\u5728\u4f26\u7406\u6279\u51c6\u540e\u5f00\u59cb IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c","description":"Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u8fd9\u662f\u5f00\u59cb\u5176\u591a\u7528\u9014\u6297\u708e\u836f IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u524d\u7684\u6700\u540e\u4e00\u4e2a\u76d1\u7ba1\u969c\u788d\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Incannex Healthcare \u5c06\u5728\u4f26\u7406\u6279\u51c6\u540e\u5f00\u59cb IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c","og_description":"Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u8fd9\u662f\u5f00\u59cb\u5176\u591a\u7528\u9014\u6297\u708e\u836f IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u524d\u7684\u6700\u540e\u4e00\u4e2a\u76d1\u7ba1\u969c\u788d\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval\/","og_site_name":"smallcapsCN","article_published_time":"2022-07-21T05:08:10+00:00","article_modified_time":"2023-08-29T17:54:54+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Incannex-Healthcare-ASX-IHL-phase-1-clinical-trial-IHL-675A-inflammatory-lung-conditions-bowel-disease-rheumatoid-arthritis.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval\/","url":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval\/","name":"Incannex Healthcare \u5c06\u5728\u4f26\u7406\u6279\u51c6\u540e\u5f00\u59cb IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2022-07-21T05:08:10+00:00","dateModified":"2023-08-29T17:54:54+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u8fd9\u662f\u5f00\u59cb\u5176\u591a\u7528\u9014\u6297\u708e\u836f IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u524d\u7684\u6700\u540e\u4e00\u4e2a\u76d1\u7ba1\u969c\u788d\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-phase-1-clinical-trial-ihl-675a-following-ethics-approval\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Incannex Healthcare \u5c06\u5728\u4f26\u7406\u6279\u51c6\u540e\u5f00\u59cb IHL-675A \u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5503"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5503"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5503\/revisions"}],"predecessor-version":[{"id":15382,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5503\/revisions\/15382"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18751"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}